RENINAAV Dose-Dependently Exacerbate Albumninuria and Glomerulosclerosis, and Reduce GFR in Female Uninephrectomized DB/DB Mice

Mette Viberg Østergaard1, Rune Ida1, Annemarie Aarup Pedersen,Thomas Secher, Frederikke Emilie Sembach, Sebastian Tølbøl Thrane, Urmas Roostalu, Keld Fosgerau, Lisbeth N Fink, Niels Vrang, "Dose Escalating Toxicology Study of ELP-VEGF, a Novel Biologic for Renal Therapeutic Angiogenesis," ERA-EDTA Meeting 2020, Nephrology Dialysis Transplantation 35 (Supplement 3):P0990.